Quantitative magnetic resonance imaging of brain atrophy in a mouse model of NiemannPick type C disease

John W. Totenhagen, Adam Bernstein, Eriko S. Yoshimaru, Robert P. Erickson, Theodore P. Trouard

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

In vivo magnetic resonance imaging (MRI) was used to investigate regional and global brain atrophy in the neurodegenerative Niemann Pick Type C1 (NPC1) disease mouse model. Imaging experiments were conducted with the most commonly studied mouse model of NPC1 disease at early and late disease states. High-resolution in vivo images were acquired at early and late stages of the disease and analyzed with atlas-based registration to obtain measurements of twenty brain region volumes. A two-way ANOVA analysis indicated eighteen of these regions were different due to genotype and thirteen showed a significant interaction with age and genotype. The ability to measure in vivo neurodegeneration evidenced by brain atrophy adds to the ability to monitor disease progression and treatment response in the mouse model.

Original languageEnglish (US)
Article numbere0178179
JournalPloS one
Volume12
Issue number5
DOIs
StatePublished - May 2017

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Fingerprint Dive into the research topics of 'Quantitative magnetic resonance imaging of brain atrophy in a mouse model of NiemannPick type C disease'. Together they form a unique fingerprint.

  • Cite this